Related Experiment Video
Updated: May 17, 2026

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
[Pulmonary toxicity resulting from the use of nitrofurantoin]
Marieke J M Broes1, Bob F W R Roelofs, Aart H Mudde
1Jeroen Bosch Ziekenhuis, afd. Interne Geneeskunde, 's-Hertogenbosch, the Netherlands. mariekebroes@gmail.com
Abstract:
Acute pulmonary syndrome is an uncommon but severe adverse reaction to nitrofurantoin. This syndrome is seldom recognised at the moment of presentation, which potentially subjects patients to unnecessary treatment and delays in the discontinuation of nitrofurantoin. We discuss the case histories of an 80-year-old and an 81-year-old woman, each presenting with acute pulmonary syndrome after nitrofurantoin administration. The diagnosis of acute pulmonary syndrome should be considered in patients presenting with fever, dyspnoea, dry cough, leukocytosis (typically with eosinophilia) and a bilateral interstitial pattern visible on the chest X-ray after having started nitrofurantoin. The prognosis is excellent if the condition is recognised early and the exposure to nitrofurantoin is discontinued.
Related Concept Videos
Drug Toxicity: Dose-Dependent Reactions
Inhibitors of Bacterial DNA Synthesis
2° Amines to N-Nitrosamines: Reaction with NaNO2
Drug toxicity: Drug–Drug Interaction
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
